Article
Metformin improves monosodium-iodoacetate-induced osteoarthritis via regulation of pain mediators and autophagy-lysosomal pathway.
2020-02-10
Abstract excerpt
<h4>Background: </h4> Osteoarthritis (OA) is the most common degenerative arthritis associated with pain and cartilage destruction in the elderly. Its pathogenesis involves inflammatory pathways. Metformin is used to treat type 2 diabetes but also exhibits regulation of autophagy pathway. This study investigated the ability of metformin to ameliorate the severity of monosodium iodoacetate (MIA)-induced OA in rats....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d191a55c-10b7-5e86-a449-719b8fb239e7
- DOI
- 10.21203/rs.2.23029/v1
